Ads
related to: eli lilly stock priceView Our Resources & Most Popular FAQs, We May Already Have An Answer For You. Pursue Your Financial Goals With Stocks, Options, ETFs, Mutual Funds, and More
Is It Time to Invest in Companies at the Forefront of Using Advanced Robotics? An AI Revolution Could Reshape Many Industries. Read The Long View to Find Out More.
Magnify Your Bull & Bear Exposure to Biotech with Daily 3X Leverage. Daily 3X S&P Biotech Bull & Bear ETFs. Think Direction. Trade. Learn more.
Using their trading system, Zack's experts give you their prediction for LLY in free RPT. Eli Lilly's new earnings have just released, discover why they're capturing attention
Maximize Your Profit Potential with this AI Stock Investment Guide. Download free today to access the tickers and research on all our top AI stock picks
Search results
Stock analysis for Eli Lilly & Co (LLY:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the second quarter of 2024 of $1.30 per share on outstanding common stock. PR Newswire • 3 days ago LLY
4 days ago · Nasdaq provides market information on after hours trading daily from 4:15 p.m. ET to 3:30 p.m. ET on the following day. Get the latest updates on Eli Lilly and Company Common Stock (LLY) after ...
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology. In depth view into LLY (Eli Lilly) stock including the latest price, news, dividend ...
Nov 12, 2022 · Incidentally, the day after the fake Eli Lilly accounts had issued their fake insulin tweets, Eli Lilly’s stock share price tumbled by 4.37% or $16.08 down to $352.30 as blue check-marked ...
The 22 analysts with 12-month price forecasts for Eli Lilly stock have an average target of 737.05, with a low estimate of 500 and a high estimate of 1000. The average target predicts a decrease of -3.02% from the current stock price of 760.00. Analyst Consensus: Strong Buy.
09:57AM. Wolfe Research Adjusts Price Target on Eli Lilly to $909 From $813. (MT Newswires) 08:30AM. Barclays Adjusts Price Target on Eli Lilly and Company to $913 From $810. (MT Newswires) 08:21AM. BMO Capital Adjusts Eli Lilly Price Target to $1,001 From $900.
Ads
related to: eli lilly stock priceView Our Resources & Most Popular FAQs, We May Already Have An Answer For You. Pursue Your Financial Goals With Stocks, Options, ETFs, Mutual Funds, and More
Is It Time to Invest in Companies at the Forefront of Using Advanced Robotics? An AI Revolution Could Reshape Many Industries. Read The Long View to Find Out More.
direxion.com has been visited by 100K+ users in the past month
Magnify Your Bull & Bear Exposure to Biotech with Daily 3X Leverage. Daily 3X S&P Biotech Bull & Bear ETFs. Think Direction. Trade. Learn more.
